Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
US7309604B2 · kind B2 · utility
4Cited by
27References
86Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 24, 2005 |
| Grant date | Dec 18, 2007 |
| Priority date | — |
| Expiry date | Aug 30, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.